Clinical Trials Directory

Trials / Completed

CompletedNCT02650947

Sucralose Effects on Glucose Metabolism and Gut Microbiota

Effects of Sucralose Consumption on Glucose Metabolism, Incretin and Gut Microbiota in Healthy Adult

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
15 (actual)
Sponsor
Ramathibodi Hospital · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Accepted

Summary

Hypothesis: 1. Long-term consumption of sucralose may effect glucose metabolism, incretin hormone secretion and gut microbiota in healthy adults. 2. Long-term consumption of sucralose may alter food behaviour in healthy adults.

Detailed description

Artificial sweeteners such as sucralose, are among the most widely used food additives worldwide. Artificial sweetener consumption is considered safe and beneficial owing to their low caloric content. However, many emerging evidences showed artificial sweeteners may induce glucose intolerance. The objectives of this study were to determine the effect of sucralose on glycemic response, insulin secretion, insulin sensitivity, incretin response, gut microbiota and food behavior in healthy subjects.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTSucraloseConsumption of capsules containing either 200 mg sucralose (equivalent to diet soda 3 cans) per day for four weeks
DIETARY_SUPPLEMENTPlaceboConsumption of empty capsule everyday for 4 weeks

Timeline

Start date
2016-01-01
Primary completion
2017-04-01
Completion
2017-04-01
First posted
2016-01-08
Last updated
2017-04-27

Locations

1 site across 1 country: Thailand

Source: ClinicalTrials.gov record NCT02650947. Inclusion in this directory is not an endorsement.

Sucralose Effects on Glucose Metabolism and Gut Microbiota (NCT02650947) · Clinical Trials Directory